GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valbiotis SA (XPAR:ALVAL) » Definitions » Price-to-Funds-From-Operations

Valbiotis (XPAR:ALVAL) Price-to-Funds-From-Operations : (As of Jun. 05, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Valbiotis Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Valbiotis (XPAR:ALVAL) Business Description

Industry
Traded in Other Exchanges
Address
12F rue Paul VATINE, Perigny, La Rochelle, FRA, 17180
Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of major metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.